BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2014
View Archived Issues
Heptares achieves research milestone in antibody collaboration with MedImmune
Read More
Johnson & Johnson reports regulatory news of fourth quarter 2013
Read More
Identification of RNA transcription enzyme repressors as novel anticancer drugs
Read More
Dendrimer-enhanced docetaxel clinical trial to begin in patients with solid tumors
Read More
Amgen reports topline data from phase III GAUSS-2 trial
Read More
Kancera to develop a vaccine against ROR to prevent cancer relapse
Read More
BioLineRx receives FDA orphan drug designation for stem cell mobilization therapy
Read More
California Stem Cell submits phase II trial protocol to FDA for Ovapuldencel-T
Read More
Pfizer reports topline results from phase III study of ALO-02
Read More
CytRx begins phase II trial of aldoxorubicin for AIDS-related Kaposi's sarcoma
Read More
DiaGenic reports final results from exploratory study of blood test for Alzheimer's disease
Read More
MDxHealth and Teva Pharmaceuticals sign agreement to commercialize two cancer tests in Israel
Read More
Japanese researchers present novel GSK-3 inhibitors for cancer
Read More
Roche discloses new agents for HCV infection
Read More
FDA grants orphan drug status to Aeolus' drug candidate for treatment of acute radiation syndrome
Read More
Novel fatty acid synthase inhibitors patented by GlaxoSmithKline
Read More
Novel PCSK9 inhibitors designed by Cadila Healthcare for dyslipidemia
Read More
Isis Innovation divulges new RNA polymerase inhibitors for infections
Read More
Novartis to request re-examination of E.U. filing for serelaxin
Read More
EMA committee recommends approval of Xolair in new indication
Read More
Endo and BioDelivery report results from phase III trial of BEMA buprenorphine in chronic pain
Read More
Valeant completes acquisition of Solta Medical
Read More
KIF20A-derived peptide plus gemcitabine evaluated in pancreatic cancer trial
Read More
Previously identified RIP1 kinase inhibitor potentially useful for necroptosis
Read More